Mingwei Fu
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Yining Li (8 shared papers)Jianyun Yan (8 shared papers)Qianqian Dong (8 shared papers)An Chen (7 shared papers)Xiaoyu Liu (7 shared papers)Lihe Lu (7 shared papers)Yuanzhi Ye (7 shared papers)Zirong Lan (7 shared papers)
- Journals
- Blood (4 papers)Kidney International (2 papers)Crystal Growth & Design (2 papers)Journal of Molecular and Cellular Cardiology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Mingwei Fu
30 papers receiving 591 citations
Mingwei Fu's Hit Papers
Peers
Comparison fields: 5 of 84
- Nephrology 76
- Cancer Research 111
- Geriatrics and Gerontology 21
- Pulmonary and Respiratory Medicine 196
- Molecular Biology 204
Countries citing papers authored by Mingwei Fu
This map shows the geographic impact of Mingwei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Fu more than expected).
Fields of papers citing papers by Mingwei Fu
This network shows the impact of papers produced by Mingwei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Fu. The network helps show where Mingwei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingwei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification Hit paper breakdown → | 2022 | 265 |
| 2 | 2021 | 75 | |
| 3 | 2023 | 47 | |
| 4 | 2021 | 46 | |
| 5 | 2022 | 40 | |
| 6 | 2020 | 26 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 11 | |
| 9 | 2009 | 10 | |
| 10 | 2025 | 5 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2024 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2014 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2015 | 3 | |
| 20 | 2007 | 2 |
About Mingwei Fu
Mingwei Fu is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 591 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Crystallography and molecular interactions (3 papers), CAR-T cell therapy research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Enzyme Structure and Function (2 papers) and Crystallization and Solubility Studies (2 papers). The work is most often cited by research in Nephrology (76 citations), Cancer Research (111 citations), Geriatrics and Gerontology (21 citations), Pulmonary and Respiratory Medicine (196 citations) and Molecular Biology (204 citations). Mingwei Fu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yining Li, Jianyun Yan, Qianqian Dong, An Chen, Xiaoyu Liu, Lihe Lu, Yuanzhi Ye, Zirong Lan, Qingchun Liang and Jing‐Song Ou. Their work appears in journals such as Blood, Kidney International, Crystal Growth & Design, Journal of Molecular and Cellular Cardiology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.